PubRank

A Tzakis

Author PubWeight™ 291.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993 8.76
2 Kidney transplantation under FK 506. JAMA 1990 7.45
3 The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991 6.89
4 Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989 5.78
5 Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990 5.01
6 Baboon-to-human liver transplantation. Lancet 1993 4.01
7 Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991 3.85
8 Transplantation of multiple abdominal viscera. JAMA 1989 3.59
9 Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc 1991 3.40
10 Kidney transplantation under FK 506 immunosuppression. Transplant Proc 1991 3.31
11 Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron 1987 3.26
12 A multifactorial system for equitable selection of cadaver kidney recipients. JAMA 1987 3.01
13 Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987 2.95
14 Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995 2.95
15 Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc 1988 2.85
16 The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995 2.68
17 Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991 2.59
18 FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994 2.50
19 A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991 2.49
20 Liver transplantation across ABO blood groups. Surgery 1986 2.39
21 The antibody crossmatch in liver transplantation. Surgery 1986 2.33
22 The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994 2.32
23 Liver transplantation for type IV glycogen storage disease. N Engl J Med 1991 2.31
24 FK 506 in clinical kidney transplantation. Transplant Proc 1991 2.29
25 Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc 1991 2.26
26 Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995 2.25
27 Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994 2.20
28 One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc 1991 2.10
29 The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients. J Okla State Med Assoc 1995 2.02
30 Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988 1.89
31 Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 1992 1.85
32 Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989 1.82
33 Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc 1993 1.78
34 Small intestinal transplantation in humans with or without the colon. Transplantation 1994 1.74
35 Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001 1.72
36 Liver transplantation for polycystic liver disease. Arch Surg 1990 1.61
37 The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc 1991 1.60
38 Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 1.59
39 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
40 Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989 1.58
41 New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991 1.56
42 Morphological monitoring of human small bowel allografts. Transplant Proc 1993 1.52
43 Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol 1988 1.50
44 Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988 1.45
45 Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990 1.43
46 Intestinal transplantation at the University of Pittsburgh. Transplant Proc 1994 1.42
47 Adverse effects associated with the use of FK 506. Transplant Proc 1991 1.41
48 Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc 1988 1.38
49 FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 1991 1.37
50 Abdominal multivisceral transplantation. Transplantation 1995 1.37
51 Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc 1987 1.36
52 Neurologic complications of FK 506. Transplant Proc 1991 1.34
53 Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg 1994 1.33
54 Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transpl Infect Dis 2008 1.29
55 Liver transplantation for hepatocellular carcinoma. World J Surg 1995 1.26
56 Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol 1987 1.24
57 Infectious complications after small bowel transplantation in adults. Transplant Proc 1994 1.24
58 Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992 1.24
59 Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc 1991 1.24
60 Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987 1.23
61 Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). Transplantation 1992 1.23
62 Liver transplantation in older patients. N Engl J Med 1987 1.20
63 Childbearing after liver transplantation. Transplantation 1990 1.19
64 Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation 1993 1.17
65 Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994 1.16
66 Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther Drug Monit 1999 1.15
67 A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant 1994 1.15
68 The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc 1987 1.13
69 Liver transplantation in patients with patent splenorenal shunts. Surgery 1987 1.12
70 Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 1997 1.12
71 Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997 1.09
72 Human islet isolation and purification from pediatric-age donors. Transplant Proc 1991 1.09
73 Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993 1.08
74 Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant 1990 1.07
75 Endoscopy is essential for early detection of rejection in small bowel transplant recipients. Transplant Proc 1994 1.06
76 Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc 1991 1.06
77 Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990 1.05
78 Current status of FK 506 in liver transplantation. Transplant Proc 1991 1.04
79 Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol 1994 1.03
80 The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest 1997 1.02
81 Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation 1989 1.02
82 FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc 1991 1.01
83 Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 1998 1.01
84 FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. Transplant Proc 1991 1.00
85 Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis 1991 0.99
86 Rejection of human intestinal allografts: alone or in combination with the liver. Transplant Proc 1994 0.99
87 Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc 1994 0.99
88 Prospects of clinical xenotransplantation. Transplant Proc 1994 0.98
89 Pediatric renal transplantation under FK 506 immunosuppression. Transplant Proc 1991 0.98
90 Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. Transplant Proc 2006 0.98
91 Composition of human islet cell preparations for transplantation. Acta Diabetol 1992 0.97
92 Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993 0.96
93 Course of enterovesical fistulas in Crohn's disease. Am J Surg 1984 0.95
94 Liver transplantation in black recipients: Pittsburgh. Transplant Proc 1989 0.95
95 An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 1996 0.94
96 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
97 Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus. Pharmacotherapy 2000 0.92
98 Clinical intestinal transplantation. Transplant Proc 1993 0.92
99 The effect of prednisone on pancreatic islet autografts in dogs. Surgery 1993 0.92
100 Liver transplantation for hepatopulmonary syndrome due to noncirrhotic portal hypertension. Transplant Proc 2011 0.91
101 Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc 1989 0.91
102 Routine use of auxiliary partial orthotopic liver transplantation for children with fulminant hepatic failure: Preliminary report. Transplant Proc 2006 0.90
103 Intestinal transplantation in humans under FK 506. Transplant Proc 1993 0.90
104 Donor selection and surgical technique for en bloc liver-small bowel graft procurement. Transplant Proc 1993 0.90
105 Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 1994 0.90
106 The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 1999 0.90
107 Predisposing factors of diminished survival in simultaneous liver/kidney transplantation. Am J Transplant 2012 0.89
108 Herpes simplex colitis in a child with combined liver and small bowel transplant. Pediatr Transplant 2001 0.89
109 Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy. Transplant Proc 1997 0.89
110 In vivo effect of FK506 on human pancreatic islets. Transplantation 1991 0.89
111 Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993 0.89
112 Pediatric renal transplantation under FK-506 immunosuppression. J Urol 1992 0.89
113 Bacterial infections after intestine and multivisceral transplantation. Transplant Proc 2003 0.89
114 Human islet allotransplantation under FK 506. Transplant Proc 1991 0.89
115 Insulin independence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal exenteration. Transplant Proc 1995 0.88
116 Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation 1987 0.87
117 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
118 Modulatory effects of human donor bone marrow cells on allogeneic cellular immune responses. Transplantation 1997 0.87
119 The anterior route for arterial graft conduits in liver transplantation. Transpl Int 1989 0.86
120 Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc 1988 0.86
121 Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. J Hepatol 1994 0.86
122 Pediatric kidney transplantation at the University of Pittsburgh. Transplant Proc 1994 0.86
123 Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron 1987 0.85
124 Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992 0.85
125 Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993 0.84
126 Multivisceral and intestinal transplantation. Transplant Proc 1992 0.84
127 Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis 2009 0.84
128 CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients. Transplant Proc 2006 0.83
129 Cambridge-Miami score for intestinal transplantation preoperative risk assessment: initial development and validation. Transplant Proc 2010 0.83
130 Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc 1991 0.83
131 Clinical and endoscopic features of rejection in small bowel transplant recipients. Transplant Proc 1994 0.83
132 Infectious complications after human small bowel transplantation. Transplant Proc 1992 0.82
133 T cell lymphoma involving the graft of a multivisceral organ recipient. Transplantation 1999 0.82
134 Improving results of pediatric renal transplantation. J Am Coll Surg 1994 0.82
135 Allogeneic hematopoietic stem cell transplantation in recipients of cellular or solid organ allografts. Cancer Treat Res 1999 0.82
136 Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. Transplantation 1999 0.82
137 Bile leakage following T-tube removal in orthotopic liver transplantation. Hepatogastroenterology 1999 0.82
138 Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc 1991 0.82
139 Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus. Clin Nephrol 2011 0.82
140 Uterine transplantation research: laboratory protocols for clinical application. Mol Hum Reprod 2011 0.82
141 Split liver transplantation. Transplant Proc 2011 0.82
142 Neurodevelopmental outcomes of infant multivisceral transplant recipients: a longitudinal study. Transplant Proc 2006 0.82
143 Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991 0.81
144 Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery 1988 0.81
145 Hepatic artery pseudoaneurysm ligation after orthotopic liver transplantation--a report of 7 cases. Transplantation 1992 0.81
146 A new technique for isolating and culturing human hepatocytes from whole or split livers not used for transplantation. Cell Transplant 1995 0.81
147 Liver transplant for the septuagenarians: importance of patient selection. Transplant Proc 2004 0.81
148 A simplified technique for the treatment of simple pleural effusions. Surg Gynecol Obstet 1987 0.81
149 Small bowel transplantation: current progress and clinical application. Hepatogastroenterology 1996 0.81
150 Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol 1992 0.81
151 Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 1992 0.81
152 Human liver xenotransplantation. Xeno 1993 0.81
153 Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. Transplant Proc 1993 0.81
154 Preservation of livers with UW or Euro-Collins' solution. Transplantation 1988 0.80
155 Multivisceral transplantation without the liver. Transplant Proc 2002 0.80
156 Inclusion of spleen in pediatric multivisceral transplantation. Transplant Proc 2006 0.80
157 Renal function after pediatric intestinal transplant. Transplant Proc 2006 0.80
158 Multivisceral ex vivo surgery for tumors involving celiac and superior mesenteric arteries. Am J Transplant 2012 0.80
159 Neuodevelopmental outcomes for children transplanted under the age of 3 years. Transplant Proc 2006 0.80
160 Preclinical report on allogeneic uterus transplantation in non-human primates. Hum Reprod 2012 0.80
161 A new technique of extravesical ureteroneocystostomy for renal transplantation. Transplant Proc 1989 0.80
162 Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. Transplant Proc 2005 0.80
163 Liver transplantation in patients with situs inversus. Clin Transplant 1990 0.80
164 Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. Transplant Proc 1991 0.80
165 The role of liver transplantation in the subacute trauma patients. Am Surg 1998 0.79
166 Gene expression profiling of MicroRNAs in small-bowel transplantation paraffin-embedded mucosal biopsy tissue. Transplant Proc 2010 0.79
167 Mycophenolate mofetil-related gastrointestinal mucosal injury in multivisceral transplantation. Transplant Proc 2010 0.79
168 Routine use of the piggyback technique in pediatric orthotopic liver transplantation. J Pediatr Surg 1996 0.79
169 Pediatric liver transplantation. History, recent innovations, and outlook for the future. Clin Pediatr (Phila) 1993 0.79
170 Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism. Transplant Proc 1997 0.79
171 Intraoperative donor cholangiography. Liver Transpl Surg 1998 0.79
172 Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989 0.79
173 Donor bone marrow, chimerism, histocompatibility and renal allograft rejection. Transplant Proc 1999 0.79
174 Detection of pancreatic islet tissue following islet allotransplantation in man. Transplantation 1991 0.79
175 Analysis of rejection episodes in over 100 pediatric intestinal transplant recipients. Transplant Proc 2006 0.79
176 Partial bladder transplantation with en bloc kidney transplant--the first case report of a 'bladder patch technique' in a human. Am J Transplant 2008 0.79
177 Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. Transplant Proc 1998 0.79
178 Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center. Transplant Proc 2006 0.78
179 Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004 0.78
180 Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc 1994 0.78
181 Neurodevelopmental outcomes of infant intestinal transplant recipients. Transplant Proc 2004 0.78
182 Donor bone marrow infusion in renal transplantation. Transplant Proc 1998 0.78
183 Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. Transplant Proc 1995 0.78
184 Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. Gastroenterology 1999 0.78
185 Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 1992 0.78
186 Multivisceral transplantation for pediatric intestinal pseudo-obstruction: single center's experience of 16 cases. Transplant Proc 2004 0.78
187 Donor bone marrow infusions are tolerogenic in human renal transplantation. Transplant Proc 2001 0.78
188 Intestinal transplantation for short bowel syndrome secondary to gastroschisis. J Pediatr Surg 2006 0.78
189 Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transplant Proc 2001 0.78
190 Current status of intestinal transplantation. Adv Surg 1994 0.78
191 Use of donor aorta for arterial reconstruction in paediatric liver and multivisceral transplantation. Br J Surg 2004 0.78
192 Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant 1998 0.77
193 Cellular composition of islet cell suspensions for transplantation. Transplant Proc 1992 0.77
194 Intestinal transplantation at the University of Miami. Transplant Proc 2002 0.77
195 Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. Transplant Proc 1996 0.77
196 Kidney transplantation in Pittsburgh: experience and innovations. Clin Transpl 1987 0.77
197 Candidates for intestinal transplantation and possible indicators of outcome. Transplant Proc 1994 0.77
198 Transplant-associated autoimmune mechanisms in human hepatitis C virus infection. J Clin Immunol 1996 0.77
199 Intestinal transplantation: 4-year experience. Transplant Proc 1995 0.77
200 Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. Transplant Proc 1994 0.77
201 Biliary tract complications in orthotopic adult liver transplantation. Am J Surg 1989 0.77
202 Human islet allotransplantation in 18 diabetic patients. Transplant Proc 1992 0.76
203 Twelve years' experience with non-heart-beating cadaveric donors. J Transpl Coord 1996 0.76
204 PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes. Transplant Proc 1997 0.76
205 Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int 1995 0.76
206 Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years. Transplant Proc 1998 0.76
207 Overview of FK506 in transplantation. Clin Transpl 1990 0.76
208 The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up. Transplantation 1997 0.76
209 Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991 0.76
210 Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. Transplant Proc 1995 0.76
211 Vitiligo improvement in a hepatitis C patient after treatment with PEG-interferon alpha-2a and ribavirin: a case report. Dig Dis Sci 2007 0.76
212 In situ quantitative immunoprofiling of regulatory T cells using laser scanning cytometry. Transplant Proc 2009 0.76
213 Epithelial and hematopoietic cell chimerism in intestinal allografts. Transplant Proc 2004 0.76
214 Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. Transplantation 1991 0.76
215 Non-tuberculous mycobacterial associated enterocolitis in intestinal transplantation. Transplant Proc 1998 0.75
216 Abnormal gastric emptying after intestinal transplantation. Transplant Proc 1994 0.75
217 FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. Transplant Proc 1994 0.75
218 Assessment of the effects of cadaveric donor bone marrow on chimerism in kidney transplant recipients by the polymerase chain reaction-flow technique. Transplant Proc 1997 0.75
219 Notes on FK 506. Transplant Proc 1991 0.75
220 Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. Transplant Proc 1992 0.75
221 Outcome of human islet isolation and allotransplantation in 20 consecutive cases. Diabetes Nutr Metab 1992 0.75
222 The use of pulmonary artery sequestration as an hepatic arterial conduit. A case of unusual hepatic arterial supply. Transplantation 1989 0.75
223 Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. Transplant Proc 2006 0.75
224 The transplantation of gastrointestinal organs. Gastroenterology 1993 0.75
225 Pancreas procurement from multiorgan donors for islet trasplantation. Diabetes Nutr Metab 1992 0.75
226 Survival of human hepatocellular aggregates in athymic mice. Transplant Proc 1992 0.75
227 Basic considerations for the procurement of intestinal grafts. Transplant Proc 1994 0.75
228 Detection of intrahepatic human islets following combined liver-islet allotransplantation. Pancreas 1992 0.75
229 Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 1991 0.75
230 Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 1992 0.75
231 Use of the D-xylose absorption test in monitoring intestinal allografts. Transplant Proc 1994 0.75
232 Histologic finding of pancreatic islet tissue following intraportal human islet allotransplantation. Transplant Proc 1992 0.75
233 Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients. Transplant Proc 1998 0.75
234 In vivo and in vitro effect of FK 506 on rat Leydig cell function. Transplant Proc 1991 0.75
235 Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. Transplant Proc 1991 0.75
236 Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994 0.75
237 Islet transplantation in type II diabetes. Transplant Proc 1995 0.75
238 Lymphoplasmacytic hyperplasia (possibly pre-PTLD) has varied expression and appearance in intestinal transplant recipients receiving Campath immunosuppression. Transplant Proc 2004 0.75
239 Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. Transplant Proc 1994 0.75
240 Cloning and expression of canine interleukin-10. J Interferon Cytokine Res 1995 0.75
241 Assessment of homozygosity in HLA-class I antigens and their distribution/quantitation in subpopulations of T cells by flow cytometry. Transplant Proc 1997 0.75
242 Immunoenzymatic and morphological detection of epithelial cell apoptotic stages in gastrointestinal allografts from multivisceral transplant patients. Transplant Proc 2004 0.75
243 Growth after intestinal transplant in children. Transplant Proc 2006 0.75
244 Toward the biologic release of human insulin from skeletal muscle. Transplant Proc 1997 0.75
245 Flow cytometric DNA analysis of paraffin-embedded hepatocellular carcinoma from patients treated by orthotopic liver transplantation. Transplant Proc 1997 0.75
246 Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine values. Transplant Proc 2001 0.75
247 Backtable angioscopy to evaluate the renal artery. Transplantation 1992 0.75
248 Preliver transplant viremic status and the choice of anti-HBV regimens. Transplant Proc 2001 0.75
249 Rat enterocyte cultures on human amniotic membranes. Transplant Proc 2004 0.75
250 International grading scheme for acute rejection in small bowel transplantation: implementation and experience at the University of Miami. Transplant Proc 2006 0.75
251 Sirolimus (rapamycin)-based rescue treatment following chronic rejection after liver transplantation. Transplant Proc 2001 0.75
252 Mucosal fibrosis in intestinal transplant biopsies correlates positively with the development of chronic rejection. Transplant Proc 2006 0.75
253 FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience. Transplant Proc 1997 0.75
254 Surgical considerations in liver transplantation: small for size syndrome. Panminerva Med 2009 0.75
255 Rituximab treatment for posttransplantation lymphoproliferative disorder after small bowel transplantation. Transplant Proc 2002 0.75
256 Induction therapy for adult small bowel transplant with Campath-1H. Transplant Proc 2002 0.75
257 Cadaveric small bowel/split liver transplantation in a child. Transpl Int 1999 0.75
258 Outcome of exfoliative rejection after isolated intestinal transplantation in an adult: case report. Transplant Proc 2010 0.75
259 Male enterocytes in female intestinal grafts. Transplant Proc 2002 0.75
260 Thoracoabdominal bypass graft with liver retransplantation for the treatment of a pseudoaneurysm of the supraceliac aorta after liver transplantation. Pediatr Transplant 2001 0.75
261 Semiquantitative measurement of mucosal fibrosis as a means of assessing chronic injury in bowel allografts. Transplant Proc 2002 0.75
262 Combined liver-islet allotransplantation in man under FK 506. Transplant Proc 1991 0.75
263 Immunophenotyping and cellular immune responses of cadaveric donor bone marrow cells. Transplant Proc 1998 0.75
264 Pediatric liver transplant with Campath 1H induction--Preliminary report. Transplant Proc 2006 0.75
265 Temporary elevation of serum transaminases after pediatric intestinal transplantation: incidence and clinical correlation in multivisceral transplant vs isolated intestinal transplant. Transplant Proc 2006 0.75
266 Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. Transplant Proc 1998 0.75
267 Portosystemic shunt for the treatment of portal vein thrombosis following orthotopic liver transplantation. Transpl Int 1994 0.75
268 Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression. Transplant Proc 1998 0.75
269 Percutaneous approach for human islet transplantation. Transplant Proc 1992 0.75
270 Sclerosing mesenteritis in small bowel transplantation: possible manifestation of acute vascular rejection. Transplant Proc 2003 0.75
271 Small bowel transplantation in children. Pediatr Transplant 1997 0.75
272 Etiology and management of alimentary tract ulcers in pediatric intestinal transplantation patients. Transplant Proc 2006 0.75
273 Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplant Proc 1997 0.75
274 Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection. Transplant Proc 1999 0.75
275 Liver transplantation today. Postgrad Med 1987 0.75
276 Intestinal transplantation for trauma patients. Transplant Proc 2002 0.75
277 Management of allograft-replaced right hepatic arteries in liver transplantation: a review of the University of Miami experience and a preferred method of reconstruction. Transplant Proc 1997 0.75
278 The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. Transplant Proc 1995 0.75
279 Expanded use of multivisceral transplantation for small children with concurrent liver and intestinal failure. Transplant Proc 2006 0.75
280 Vertebral body procurement from multiorgan donors for bone marrow harvest. Transplant Proc 1997 0.75
281 Initial studies with FK506 in renal transplantation. Cleve Clin J Med 1991 0.75
282 Mucosal vascular alterations in the early posttransplant period of small bowel allograft recipients may reflect humoral-based allograft rejection. Transplant Proc 2002 0.75
283 Use of percutaneous liver biopsies in marginal liver donors. Transplant Proc 2001 0.75
284 Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. Transplant Proc 2003 0.75
285 Study of the development and evolution of neointestine in a rat model. Transplant Proc 2004 0.75
286 Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant 1994 0.75
287 Non-heart-beating cadaver donor hepatectomy 'the operative procedure'. Clin Transplant 1999 0.75
288 Ureteral reconstruction and bladder augmentation using intestinal allograft in a modified multivisceral transplant patient. Am J Transplant 2006 0.75
289 Bacterial infections after intestine and multivisceral transplantation. The experience of the University of Miami (1994-2001). Hepatogastroenterology 2006 0.75